1,528 Shares in Shockwave Medical, Inc. (NASDAQ:SWAV) Acquired by Valeo Financial Advisors LLC

Valeo Financial Advisors LLC acquired a new stake in Shockwave Medical, Inc. (NASDAQ:SWAV) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 1,528 shares of the company’s stock, valued at approximately $291,000.

Several other institutional investors have also recently bought and sold shares of SWAV. Covestor Ltd raised its holdings in shares of Shockwave Medical by 484.9% in the third quarter. Covestor Ltd now owns 427 shares of the company’s stock valued at $85,000 after buying an additional 354 shares during the last quarter. International Assets Investment Management LLC increased its stake in shares of Shockwave Medical by 18,122.1% in the 4th quarter. International Assets Investment Management LLC now owns 141,586 shares of the company’s stock valued at $26,981,000 after buying an additional 140,809 shares during the period. American Century Companies Inc. lifted its stake in shares of Shockwave Medical by 109.0% during the third quarter. American Century Companies Inc. now owns 170,866 shares of the company’s stock valued at $34,019,000 after acquiring an additional 89,094 shares during the period. AMI Asset Management Corp acquired a new position in shares of Shockwave Medical during the fourth quarter valued at $4,092,000. Finally, Wellington Management Group LLP increased its position in Shockwave Medical by 33.5% in the third quarter. Wellington Management Group LLP now owns 1,805,771 shares of the company’s stock worth $359,529,000 after purchasing an additional 453,048 shares during the period. Institutional investors own 95.35% of the company’s stock.

Shockwave Medical Stock Performance

Shares of SWAV opened at $327.10 on Tuesday. The firm has a market cap of $12.23 billion, a P/E ratio of 84.52, a PEG ratio of 2.45 and a beta of 0.92. Shockwave Medical, Inc. has a twelve month low of $157.00 and a twelve month high of $331.58. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. The firm’s 50 day moving average price is $278.57 and its two-hundred day moving average price is $225.46.

Shockwave Medical (NASDAQ:SWAV) last posted its quarterly earnings data on Thursday, February 15th. The company reported $1.16 EPS for the quarter, beating the consensus estimate of $0.92 by $0.24. The business had revenue of $202.98 million for the quarter, compared to analysts’ expectations of $199.43 million. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. The firm’s revenue was up 41.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.71 EPS. On average, analysts forecast that Shockwave Medical, Inc. will post 4.9 EPS for the current fiscal year.

Insider Activity at Shockwave Medical

In other news, insider Isaac Zacharias sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $224.69, for a total transaction of $898,760.00. Following the completion of the transaction, the insider now directly owns 63,920 shares of the company’s stock, valued at approximately $14,362,184.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Shockwave Medical news, Director Laura Francis sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $300.00, for a total value of $450,000.00. Following the completion of the transaction, the director now directly owns 3,551 shares in the company, valued at $1,065,300. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $224.69, for a total value of $898,760.00. Following the sale, the insider now owns 63,920 shares in the company, valued at approximately $14,362,184.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 93,813 shares of company stock valued at $23,762,679. 3.40% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

SWAV has been the topic of a number of research reports. Canaccord Genuity Group restated a “hold” rating and set a $335.00 target price (up from $263.00) on shares of Shockwave Medical in a research report on Friday, April 5th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $335.00 target price (up previously from $270.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Wells Fargo & Company raised their price target on Shockwave Medical from $200.00 to $210.00 and gave the stock an “equal weight” rating in a research report on Friday, February 16th. Piper Sandler upped their price objective on Shockwave Medical from $290.00 to $360.00 and gave the company an “overweight” rating in a report on Tuesday, April 2nd. Finally, TheStreet raised Shockwave Medical from a “c+” rating to a “b” rating in a research note on Thursday, February 15th. Ten research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Shockwave Medical currently has a consensus rating of “Hold” and a consensus price target of $309.11.

Shockwave Medical Company Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.